From: Diffuse reduction of cerebral grey matter volumes in Erdheim-Chester disease
Patient | Organ systems affected by ECD | Co-morbid illnesses | Cognitive complaints | Concurrent Medications | Inflammatory Markersa | CSF Examinationb |
---|---|---|---|---|---|---|
 66 Female | Myocardium, bones | None | No | None | ESR >100 | 1 WBC; Protein 28; Glucose 57; |
CRP 4.39 | ||||||
 75 Male | Mesentery, orbit, bones, skin | Chronic myelomonocytic leukemia | Yes | Prednisone | CRP 0.98 | - |
 54 Male | Brainstem, retroperitoneum, bones | Diabetes mellitus | No | Prednisolone | ESR 31 | 2 WBC; Protein 42; Glucose 78 |
CRP 1.8 | ||||||
 51 Male | Retroperitoneum, aorta, pericardium, pleura, bones | Essential thrombocytosis | Yes | Interferon-alpha, anakinra | - | 1 WBC; Protein 21; Glucose 54 |
 51 Male | Orbit, retroperitoneum, epidural soft tissues, bones | Ulcerative colitis | Yes | None | CRP 1.63 | - |
 60 Male | Retroperitoneum, lung, skin, bones | MALT lymphoma | Yes | Prednisone | ESR 92 | 2 WBC; Protein 33; Glucose 58 |
CRP 1.49 | ||||||
 48 Female | Orbit, retroperitoneum, bones | None | Yes | Prednisone | CRP 3.81 | - |
 66 Female | Brainstem, retroperitoneum, bones | None | Yes | Prednisone | - | 2 WBC; Protein 71; Glucose 57 |
 68 Male | Retroperitoneum, bones, subcutaneous soft tissues | None | No | None | ESR 61 | - |
CRP 6.29 | ||||||
 58 Male | Orbit, retroperitoneum, bones | None | No | Prednisone | CRP 3.42 | - |
 52 Female | Subcutaneous soft tissues, maxillary sinus, bones, skin | None | Yes | None | CRP 2.56 | - |